IRF5 polymorphism predicts prognosis in patients with systemic sclerosis - Wikidata - wikimedia - TriplyDB

IRF5 polymorphism predicts prognosis in patients with systemic sclerosis

IRF5 polymorphism predicts prognosis in patients with systemic sclerosis

http://www.wikidata.org/entity/Q36032649

about

The immune pathogenesis of scleroderma: context is everything Genetics, Epigenetics, and Genomics of Systemic Sclerosis An IRF5 Decoy Peptide Reduces Myocardial Inflammation and Fibrosis and Improves Endothelial Cell Function in Tight-Skin Mice Genetic association study of TNFAIP3, IFIH1, IRF5 polymorphisms with polymyositis/dermatomyositis in Chinese Han population.4F decreases IRF5 expression and activation in hearts of tight skin mice.Genetics of scleroderma: implications for personalized medicine?The systemic lupus erythematosus IRF5 risk haplotype is associated with systemic sclerosis.Systems level analysis of systemic sclerosis shows a network of immune and profibrotic pathways connected with genetic polymorphisms.Genetics of Interstitial Lung Disease: Vol de Nuit (Night Flight).Pathogenesis of Systemic Sclerosis.Multifaceted contribution of the TLR4-activated IRF5 transcription factor in systemic sclerosis.The role of type 1 interferon in systemic sclerosis.Genetic architecture of human fibrotic diseases: disease risk and disease progression.The primary care physician in the early diagnosis of systemic sclerosis: the cornerstone of recognition and hope.Immunochip analysis identifies multiple susceptibility loci for systemic sclerosis.A genome-wide association study follow-up suggests a possible role for PPARG in systemic sclerosis susceptibility.Exploiting induced pluripotent stem cell-derived macrophages to unravel host factors influencing Chlamydia trachomatis pathogenesis Is there evidence for vasculitis in systemic sclerosis?Current status of systemic sclerosis biomarkers: applications for diagnosis, management and drug development.Personalized medicine in systemic sclerosis: facts and promises.Polymorphisms in STAT4 and IRF5 increase the risk of systemic sclerosis: a meta-analysis.Genetics of systemic sclerosis.Association of the IRF5 SNP rs2004640 with systemic sclerosis in Han Chinese.IRF7 gene expression profile and methylation of its promoter region in patients with systemic sclerosis.Lung Involvements in Rheumatic Diseases: Update on the Epidemiology, Pathogenesis, Clinical Features, and Treatment.

P2860

Q24633658-9EABC350-A9CF-453D-9410-6576E4B9C745 Q26799577-2E8C0A24-5D33-4AA0-A279-64154A4725F8 Q28551204-5F367F81-B923-49FB-920F-3B5DE9A0DB18 Q34387392-D893F7CD-3268-4889-BC80-A7456AFD2139 Q34517543-BDD775D6-7747-4AB2-A170-79C5B96B53D6 Q34545752-1D798C63-E5B4-494B-8266-49F91A3EE63F Q34571170-C243ED13-7A70-4DDE-8F84-5D18D06B20BC Q34888501-72D2C82D-9B66-4140-9B52-89D27376D6D9 Q35649228-C4A15B28-1583-4684-960E-D889067064B4 Q35693212-E4D11685-1F7B-4028-B136-FF4895E80FB3 Q36371453-B973153C-1D0E-4696-8E3D-F144D0E66079 Q37150404-EB909DCE-AD63-42E7-B4D1-1F91AA37CCD8 Q37400152-FD7C3E86-CE19-4C45-A92E-CEDDD0CA6FD9 Q37413166-D886B9DB-C769-403A-A033-F17839E6A750 Q37441841-8E31D4D4-DF2C-40F6-B85A-CF9F365C0A1A Q37690304-6E324EC8-86E0-4E98-B548-11837FA7555A Q37834334-CEDCFBF7-E36D-4E5D-9060-037CC0F4BCBC Q38052089-79C28150-82D0-45D6-8FEA-1C4E5A19BE82 Q38156227-70C697F5-43A9-4EFC-B8E0-A29CD52EB866 Q38206152-C575EF2E-83BA-4EA3-B0A6-9DF0A0756FA8 Q38384067-55FB5453-488B-431E-A992-C65A5865DADD Q38511454-5CE3FAB1-5878-438E-9E98-9290571F62A2 Q47446383-82239B29-8478-4A5D-B4F6-3C62C7BAFB99 Q48282970-39655496-46D7-44B8-ABA6-576AC80A29CB Q55361229-4FEA1618-A632-452E-BA83-18C1A816C4DE

P2860

IRF5 polymorphism predicts prognosis in patients with systemic sclerosis

http://www.wikidata.org/entity/Q36032649

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

IRF5 polymorphism predicts prognosis in patients with systemic sclerosis

@ast

IRF5 polymorphism predicts prognosis in patients with systemic sclerosis

@en

type

label

IRF5 polymorphism predicts prognosis in patients with systemic sclerosis

@ast

IRF5 polymorphism predicts prognosis in patients with systemic sclerosis

@en

prefLabel

IRF5 polymorphism predicts prognosis in patients with systemic sclerosis

@ast

IRF5 polymorphism predicts prognosis in patients with systemic sclerosis

@en

P1433

Q36032649-89C826F3-1F42-46E0-9391-9F03D5BE78A1

P1476

Q36032649-B55EA358-39A2-4C28-982F-6E6A09B1582A

P2093

Q36032649-09F8D540-0ECF-413E-8F33-B30C54E241FA

Q36032649-0B9CA251-23D3-478A-97D9-30ED2374020F

Q36032649-17661FFB-0C0C-4DBA-BD36-8C210E4BB29F

Q36032649-1B92EAF6-E48B-48F3-93F7-EB1098D4234B

Q36032649-32939D58-79F2-4643-839B-EF3F47C830D0

Q36032649-5C50C244-A1BA-4E2D-BA50-3F98C17F7496

Q36032649-5F359A43-FA58-45B3-BA8D-828105B41D40

Q36032649-7145BA61-5B33-4DDA-863D-85CE16CDE56C

Q36032649-77EAC233-7822-44AA-9EC6-A579AEA0FF97

Q36032649-89B492D4-7945-4FAC-99F4-C28D1A7453B5

P2860

Q36032649-01F4D03B-407B-4E58-9E73-C04C42F53CC5

Q36032649-11CBE81D-EEAF-4680-8289-A6D957863890

Q36032649-23614185-BCA6-4E82-8F9E-EF4C0E5F13A4

Q36032649-2D1D1E44-19B1-4AD2-82A7-0DA0CB3CA7A5

Q36032649-43EC884F-4EF8-4819-A82C-F4DC1959C7D7

Q36032649-5271B9E4-3C62-4A1F-87B8-AD9769E75057

Q36032649-5F49E409-140E-42A4-AD18-490D4CF6535B

Q36032649-7CFE1422-1C6D-4EBB-A2CB-06ACBF4188F2

Q36032649-8F2271F6-98A4-4EE8-9FB4-7DA9557BA60A

Q36032649-A65A0995-E23D-4306-A306-4A7D17F7D948

P304

Q36032649-26F52739-507F-438B-90BE-3F6A406CD96A

P31

Q36032649-41DCCE39-637F-4C03-B10F-1F92454F70FC

P356

Q36032649-D432906A-5793-4F11-A031-BE2D9040C1EE

P407

Q36032649-CA7157CE-FA16-4780-A1AD-187052A9D955

P433

Q36032649-F6CF200B-E0CA-4769-AF54-F4770A0E8569

P478

Q36032649-B70BD1A2-BA0E-43E1-A8AF-B0D938665978

P50

Q36032649-17863F2A-E88B-4FBE-BD29-58E7EA4EEEB2

Q36032649-D6262B1A-5E8C-4B56-8326-926F5F4F6936

Q36032649-DA19CB22-E176-4203-A207-481B61E69802

Q36032649-DEAC9F06-99CC-4C97-A6E7-DAA3A06D089E

P577

Q36032649-908F6720-C46B-4A36-A803-ADD23640B908

P5875

Q36032649-C02821DF-7012-455B-83DE-E7E6196632D9

P698

Q36032649-790B1935-1270-4481-911C-D210DED5590A

P932

Q36032649-9FE8726C-9D5C-4A7D-8176-73BBAF71D279

P356

ANNRHEUMDIS-2011-200901

P1433

Annals of the Rheumatic Diseases

P1476

IRF5 polymorphism predicts prognosis in patients with systemic sclerosis

@en

P2093

Ami A Shah

http://www.w3.org/2001/XMLSchema#string

Daniel E Furst

http://www.w3.org/2001/XMLSchema#string

Dinesh Khanna

http://www.w3.org/2001/XMLSchema#string

Emilio B Gonzalez

http://www.w3.org/2001/XMLSchema#string

Filemon K Tan

http://www.w3.org/2001/XMLSchema#string

Frank C Arnett

http://www.w3.org/2001/XMLSchema#string

Fredrick M Wigley

http://www.w3.org/2001/XMLSchema#string

Hilda Torres Draeger

http://www.w3.org/2001/XMLSchema#string

Jun Ying

http://www.w3.org/2001/XMLSchema#string

Maureen D Mayes

http://www.w3.org/2001/XMLSchema#string

P2860

Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locus

Trends in mortality in patients with systemic sclerosis over 40 years: a systematic review and meta-analysis of cohort studies

Systemic sclerosis and lupus: points in an interferon-mediated continuum.

Clinical and genetic factors predictive of mortality in early systemic sclerosis.

Primary biliary cirrhosis (PBC), PBC autoantibodies, and hepatic parameter abnormalities in a large population of systemic sclerosis patients

Predictors of interstitial lung disease in early systemic sclerosis: a prospective longitudinal study of the GENISOS cohort

A primer and comparative review of major US mortality databases.

Changes in causes of death in systemic sclerosis, 1972-2002

Systemic sclerosis - continuing progress in developing clinical measures of response.

Regulation of T cell homeostasis by JAKs and STATs.

P304

1197-1202

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/ANNRHEUMDIS-2011-200901

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

71

http://www.w3.org/2001/XMLSchema#string

P50

Laura K. Hummers

Lara Bossini-Castillo

John D Reveille

P577

2012-03-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221969651

http://www.w3.org/2001/XMLSchema#string

P698

22440820

http://www.w3.org/2001/XMLSchema#string

P932

3375372

http://www.w3.org/2001/XMLSchema#string